Market Tracker

02/17 5:16pm ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.61
Delayed Data
As of Feb 17
 -0.07 / -2.61%
Today’s Change
1.83
Today|||52-Week Range
24.40
+34.54%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close2.68
Today’s open2.69
Day’s range2.56 - 2.70
Volume141,766
Average volume (3 months)412,326
Market cap$24.8M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-198.92%
Earnings growth (this year)+41.73%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+44.44%
P/E ratioNM
Price/Sales0.89
Price/Book0.48

Competitors

 Today’s
change
Today’s
% change
APRIApricus Biosciences ...+0.32+10.94%
VICLVical Inc-0.01-0.44%
HTBXHeat Biologics Inc-0.03-2.77%
CATBCatabasis Pharmaceut...0.000.00%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$3.15
Annual revenue (last year)$175.9M
Annual profit (last year)-$148.3M
Net profit margin-84.34%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
President, Chief Financial Officer &
Director
Graham G. Miao
Corporate headquarters
Morristown, New Jersey

Forecasts